A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
Clinical trial NCT04540900 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04540900
- Sponsor
- Krystal Biotech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2024-10-16
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.